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Abstract 
Rationale 
Rapid response by health-care systems for transient ischaemic attack and minor stroke 
(TIAMS) is recommended to maximize the impact of secondary prevention strategies. The 
applicability of this evidence to Australian non-hospital-based TIAMS management is 
uncertain.  
Aims 
Within an Australian community setting we seek to document processes of care, establish 
determinants of access to care, establish attack rates and determinants of recurrent vascular 
events and other clinical outcomes, establish the performance of ABC2-risk stratification, 
and compare processes of care and outcomes to those in the UK and New Zealand for 
TIAMS. 
Sample size estimates 
Recruiting practices containing approximately 51 full-time-equivalent general practitioners to 
recruit 100 TIAMs per year over a 4-year study period will provide sufficient power for each 
of our outcomes 
Methods and design 
An inception cohort study of patients with possible TIAMS recruited from 16 general 
practices in the Newcastle-Hunter Valley-Manning Valley region of Australia. Potential 
TIAMS will be ascertained by multiple overlapping methods at general practices, after-hours 
collaborative, and hospital in-patient and outpatient services. Participants’ index and 
subsequent clinical events will be adjudicated as TIAMS or mimics by an expert panel. 
Study outcomes 
4 
 
Process outcomes: whether the patient was referred for secondary care; time from event to 
first patient presentation to a health professional; time from event to specialist acute-access 
clinic appointment; time from event to brain and vascular imaging and relevant prescriptions  
Clinical outcomes: recurrent stroke and major vascular events; and Health-Related Quality of 
Life.   
Discussion 
Community management of TIAMS will be informed by this study. 
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Introduction and rationale 
Transient ischaemic attack and minor stroke (TIAMS) comprise approximately 40% of all 
episodes of brain ischaemia1,2 and carry a significant risk of disabling or fatal stroke.3 Much 
of the stroke risk occurs very early after TIAMS4 and rapid specialist assessment and 
intervention has been shown to reduce this risk.5,6 Therefore a rapid response within the 
system of care for TIAMS is required to maximize the impact of secondary prevention 
strategies.6,7 Based on this international evidence, current Australian guidelines recommend 
universal rapid-access to specialist care.8  
There are uncertainties regarding compliance with these guidelines and with the applicability 
of the current evidence and guidelines to the contemporary management of TIAMS in 
Australia beyond the hospital secondary care setting.  
Rapid-access acute neurovascular clinics, one preferred model,6 were only available in 38% 
of Australian hospitals in 20159 compared with 98% of UK hospitals 2010.10 Even in 
Australian areas with rapid-access clinics, service utilization is uncertain. Extrapolation of 
figures for populations served11,12 and TIAMS seen4,13 in acute neurovascular clinics in 
Oxfordshire and the Hunter region of Australia (where TIAMS are infrequently admitted to 
hospital) suggest that the majority of TIAMS in this Australian region are not referred for 
rapid-access management. Thus it is not clear if improvements in TIAMS outcomes evident 
in regions with more ready access to stroke specialist care7 are applicable to health systems 
such as Australia’s.  
There are uncertainties concerning TIAMS management and compliance with national 
guidelines in Australia. These include:  
1. Contemporary management and processes of care for TIAMS have not been well 
characterized in Australia nor have they been compared to international benchmarks  
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2. The performance of the Australian health care system in the management of TIAMS has 
not been examined in sufficient detail to inform or update local guidelines and health policy. 
Variations in models of care, access to stroke specialist diagnostic and management 
support, factors influencing processes of care including resource utilization and comparison 
to the UK-based models (currently an important source of evidence for Australian guidelines) 
have not been evaluated.  
3. The clinical outcomes of TIAMS have not been defined nor have the guideline-
recommended tools for risk stratification been validated in contemporary Australian 
populations, where geographic access to specialist care can be limited and many elements 
of management need to be undertaken in primary care (contrary to the current Australian 
guideline recommendations8).  
 
The aims of the International comparison of Systems of care and patient outcomes In minor 
Stroke and Tia (INSIST) study are to answer research questions related to these evidence 
gaps. Specifically:  
1. What is the process of care for a prospective cohort of possible TIAMS patients 
interacting with the Australian primary and secondary care systems? 
2. What are the determinants of access to care? 
3. What are the determinants of recurrent vascular events? 
4. What is the applicability of the internationally derived risk stratification tool ABCD214 to 
management and referral processes in Australia? 
5. How does the process of care for TIAMS in Australia influence clinical outcomes?  
6. How do processes of care and outcomes for TIAMS in Australia compare to those in 
the UK and New Zealand? 
Methods 
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Design 
INSIST is an inception cohort study in which patients with possible TIAMS are followed for 
12 months post-index event. INSIST records patients’ outcomes and their interactions with 
health care systems. 
Patient population 
Participants will be recruited from the Hunter and Manning valleys regions of New South 
Wales, within the referral territory of the Acute Neurovascular Clinic (ANVC) at the John 
Hunter Hospital (the major teaching and referral hospital of the Hunter New England Local 
Health District). These patient participants will attend one of 16 general practices within the 
Hunter New England and Central Coast Primary Health Network (HNECCPHN). The 
HNECCPHN population includes 18.3% aged 65+ years (compared to 14.4% nationally) and 
has prevalence of diabetes (4.9%) lower than nationally (5.4%) and of circulatory system 
disease (18.5%) higher than nationally (17.3%).15 INSIST will recruit urban (11) and rural 
practices (5) – including rural practices (2) in which general practitioners (GPs) staff the local 
hospitals.  
Recruitment, detailing and further engagement of general practices 
Practices will be recruited by initial contact with individual GPs, the sampling frame being the 
membership list of the Hunter Medicare Local, a comprehensive list of GPs in the Hunter 
region. Subsequent recruitment processes are adapted to variability in practice size, 
organisation, governance and processes across the region. A requirement of recruitment is 
that the practice assign a practice nurse to work on the study. 
Once a practice has agreed to participate in the study, a study investigator (PM) will visit the 
practice to orient the designated study practice nurse to the project. The study research 
manager (DQ) will then visit the practice to deliver comprehensive study procedures training 
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to the study practice nurse, including ascertainment strategies and data collection 
procedures. 
Awareness of the study and of methods will be maintained with regular visits to recruiting 
practices by study investigators (CL, PM, DL) and periodic meetings with participating 
practice nurses where the progress of the study will be reviewed, organisational issues 
discussed, and clinical education on recognition of difficult TIAMS scenarios provided.   
Ascertainment of events and recruitment of patients 
The study aims to recruit all patients with possible TIAMS to ensure full case ascertainment. 
All patients where the attending GP considers TIAMS a possible diagnosis will be invited to 
participate. This strategy reflects the ‘real world’ clinical difficulty for GPs in distinguishing 
TIAMS from mimics16 and evidence that the incidence of transient neurological symptoms in 
the population is substantially greater than the specialist-diagnosed incidence of TIA in 
hospital-based and population-based studies.17,18 Furthermore, there is evidence of variation 
in the description of TIAMS features.  Less conventional features of presentation are 
increasingly noted to be important where ‘the physical phenotype of stroke that is used as 
the basis for clinical description of TIA may not capture all of the available diagnostic 
information’.19 
Patients will be identified as potential entrants to the study cohort by multiple overlapping 
methods (see Appendix 1). 
Study participant inclusion and exclusion criteria are detailed in Appendix 2 
Recruitment of patients will be undertaken August 2012 to August 2016. Recruitment 
procedures are detailed in Appendix 3 
Data collection 
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As far as possible data to be collected is harmonised with the Oxford (UK) and Auckland 
(New Zealand) based OXVASC20 and ARCOS21 studies to enable international comparisons 
of systems of care for TIAMS.  
Participant data 
Participants will undergo baseline interview and follow-up interviews at three- and 12-months 
post-baseline assessment.  The interviews will be either via phone or home-visit, depending 
on the participant’s functional status.  For details of participant data collected, see Appendix 
4 
Following collection of baseline data, index events will be adjudicated as stroke, TIA or a 
TIAMS mimic.  The adjudication panel consists of three medical clinicians, at least one of 
which is a stroke physician and at least one of which is a GP.  The adjudication panel will 
assess available information on the participant and index event, including the participant and 
witness narratives of events, past medical history/vascular risk factors, medications, imaging 
and other test results, general practice consultation notes, referral letters, specialist 
consultation notes, and emergency department or hospital discharge letters.    
The nature of each TIAMS mimic will be adjudicated, as will be the territory of the TIAMS or 
mimic e.g. anterior (cortical, subcortical, retinal, uncertain) or posterior circulation.  If the 
participant is adjudicated to have had a TIAMS, the likely mechanism will be determined 
using the TOAST classification22  
Practice data  
Practice data collected will include practice size (both individual and full-time-equivalent GP 
numbers), rurality/urbanicity index of the practice,23 after-hours care arrangements, practice 
GP staffing arrangements in the local hospital, and distance from the practice to the ANVC. 
Hypotheses 
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1. That the majority of TIAMS patients in the Hunter region are managed exclusively in 
primary care. 
2. That rural dwelling, lower socio-economic status and advancing age will be associated 
with lower rates of referral to specialist care. 
3. That specialist care will demonstrate greater adherence to guideline-recommended 
investigation and management in comparison to exclusive GP management specifically 
for: 
a) Brain imaging 
 b) Vascular imaging 
 c) Immediate anti-platelet, blood pressure and statin therapy 
4. That referral to specialist care will result in lower recurrent vascular event rates. 
5. That referral to specialist care will result in greater quality of life 
6. That rates of recurrent vascular events will be lower than those in the international 
cohorts  
7. That rates of recurrent vascular events will be higher in lower SES bands. 
8. That the processes of care (time from event to presentation, time from presentation to 
referral to secondary care, time to secondary care assessment) will be associated with -  
a) Risk stratum (ABCD2); b) Patient factors (age, SES status, risk factors and co-
morbidities); c) Practice factors (geographical location, size of practice, out-of-hours care 
arrangements) 
Outcome measures 
Process and clinical outcomes will be determined. 
a) Process measures 
 Whether a patient is referred for secondary care or is managed entirely in general 
practice. 
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 Time from event to first presentation to a health professional. 
 For participants referred to the ANVC: time from event to clinic ANVC appointment. This 
composite outcome entails other study outcomes - time from first patient presentation to 
referral to the ANVC, time from event to referral, time from referral to ANVC 
appointment. 
 Time from event to receiving brain imaging, vascular imaging and prescriptions of anti-
platelet, anti-coagulant, antihypertensive and statin medications. 
 
b) Clinical outcomes 
 Recurrent stroke and major vascular events ascertained via: 
o Diagnosis by stroke physicians (in ANVC attendees). 
o Research nurse phone interviews with participants at baseline, 3, 6 and 12 
months 
o Research nurse examination of GP clinical records of consenting participants 
at baseline and 12 months. 
o General practice records including imaging findings. 
o Cross-referencing with the Hunter Region Heart and Stroke Register.24 
 Health Related Quality of Life  
 Disability 
 Depression and anxiety 
 Cognitive status 
 Fatigue 
(see Appendix 4 for details of instruments to be used) 
Analyses and sample size calculations 
The Hunter region population in 2011 was 620,530.11 For reference, the OXVASC study is 
conducted across a population of 91,000 individuals registered with nine Oxfordshire general 
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practices and 63 GPs.  The OXVASC catchment ascertains approximately 100 neurologist-
adjudicated TIA and 100 minor stroke cases per annum.4,20,25,26 In the Hunter region, with a 
ratio of population to Full-Time Equivalent (FTE) GPs of 1500:1, and allowing for a 
participation response rate of 60%, we needed to recruit practices containing approximately  
51 FTE GPs to recruit 100 TIAMs per year (and, thus 400 TIAMs during the study period).  
See Appendix 5 for planned analytical methods and associated sample size calculations. 
Funding. 
InSIST is funded by NHMRC Project Grant ID 1027794 
Summary and conclusions 
InSIST is an inception cohort study addressing the interactions of TIAMS patients with health 
care systems, including the primary-secondary care interface, and the outcomes of TIAMS in 
a community-based sample. It will compare processes of care and outcomes in three 
countries and provide data on which to base context-appropriate TIAMS management 
guidelines for Australian practice. 
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